Results 121 to 130 of about 427 (160)
Some of the next articles are maybe not open access.

Terapia antiagregante en el traumatismo craneoencefálico leve

Medicina Clínica, 2020
José Carlos Ruibal-Suarez   +2 more
exaly   +2 more sources

Asociación de antiagregantes, ¿cuándo y cómo?

Medicina Clínica, 2007
Aterothrombotic disease (coronary, cerebrovascular and peripheral artery disease) is the most common cause of mortality and disability in the world, antiaggregants representing one of its therapeutic and preventive pillars. We have drugs at present that act at different levels of platelet aggregation (COX inhibitors as well as inhibitors of ...
Ramiro López Menchaca   +2 more
openaire   +1 more source

Nuevos antiagregantes plaquetarios en cardiopatía isquémica

Medicina Clínica, 2014
The dual antiplatelet therapy with acetylsalicylic acid and clopidogrel has been the mainstay of both acute and chronic phase coronary artery disease, reducing importantly the risk of adverse events. Despite a correct compliance, a non-negligible rate of adverse events still happens. New compounds, with improved properties, are now clinically available
Antonio Tello-Montoliu   +2 more
openaire   +1 more source

Duración del tratamiento antiagregante en el síndrome coronario agudo

Revista Espanola De Cardiologia Suplementos, 2014
At present, dual antiplatelet therapy with aspirin and a P2Y12 receptor inhibitor is the treatment of choice for patients with acute coronary syndrome and for those undergoing percutaneous coronary interventions. Although the general recommendation is that treatment should be maintained for 12 months after the occurrence of an acute coronary syndrome ...
Héctor Bueno, José L Ferreiro
exaly   +2 more sources

Antiagregantes plaquetarios: ¿En dónde se encuentran las diferencias?

Crónicas científicas, 2017
Resumen Las guías de tratamiento apoyan el uso de antiagregantes plaquetarios como parte de la prevención y manejo de la enfermedad arterial coronaria, debido a la existencia de evidencia clínica que respalda el beneficio en la reducción de la morbimortalidad cardiovascular en pacientes post infartados que utilizan este tipo de tratamientos.
José Miguel Chaverri Fernández   +5 more
openaire   +2 more sources

Antiagregantes y anticoagulantes: manejo del paciente quirúrgico anticoagulado

Cirugía Española, 2009
Resumen Entre los grupos farmacologicos de mayor consumo por los pacientes se encuentran tanto los antiagregantes plaquetarios (aspirina, clopidogrel, ticlopidina) como los anticoagulants (acenocumarol, warfarina, heparina de bajo peso molecular, fondaparinux).
Juan V. Llau   +2 more
openaire   +1 more source

Fractura de cadera, antiagregantes plaquetarios y complicaciones postoperatorias

Revista Española de Anestesiología y Reanimación, 2013
Resumen Objetivos Evaluar la incidencia de complicaciones postoperatorias, de transfusiones sanguineas y supervivencia al mes, en los pacientes mayores intervenidos de fractura de cadera y que estaban en tratamiento cronico con antiagregantes plaquetarios. Material y metodos Se estudiaron retrospectivamente 223 pacientes intervenidos de fractura
F. Reguant   +6 more
openaire   +1 more source

Riesgo de hemorragia digestiva con aspirina y antiagregantes plaquetarios

Gastroenterología y Hepatología, 2009
Aspirin is widely used for the prevention of thrombotic cardiovascular disease. The effect of platelet antiaggregation is achieved with low doses of 75-325 mg/day. Due to COX-1 inhibition, associated gastrointestinal adverse effects can occur. Other drugs whose platelet antiaggregant effect is achieved through different mechanisms of action have been ...
Gianfranco Nardulli, Ángel Lanas
openaire   +1 more source

Tratamiento antiagregante en la trombocitemia esencial asociada al embarazo

Clínica e Investigación en Ginecología y Obstetricia, 2003
Summary The association between essential thrombocytaemia and pregnancy is infrequent. Our patient was in a thrombocytosis study when she became pregnant. She had a previous obstetric history with a poor outcome, having had a previous pregnancy interrupted in the first trimester and a threatened abortion in this pregnancy. After weighing up the risks
J. Garrigueta   +4 more
openaire   +1 more source

Home - About - Disclaimer - Privacy